![](/img/cover-not-exists.png)
PCN204 COST-ESTIMATE OF ADDING NEOADJUVANT PERTUZUMAB FOR THE TREATMENT OF HER2+ BREAST CANCER IN AN INSTITUTION IN PORTUGAL
Borges, A., Pereira, F., Redondo, P., Antunes, L., Vieira, C., Antunes, P., Bento, M.J., Sousa, S., Machado Lopes, J., Gonçalves, F.R., Abreu de Sousa, J., Pereira, D., Borges, M.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.400
Date:
November, 2019
File:
PDF, 384 KB
2019